Crossmark

Gene polymorphisms in dual antiplatelet therapy and the presence of hypo-attenuated leaflet thickening after transcatheter aortic valve replacement

Crossref DOI link: https://doi.org/10.1007/s11239-018-1636-z

Published Online: 2018-02-24

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiong, Tian-Yuan

Liao, Yan-Biao

Feng, Yuan

Zhao, Ming-Yue

Zhao, Zhen-Gang

Li, Yi-Jian

Liu, Xiao-Jing

Chen, Mao
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81370219)

Science and Technology Innovative Research Groups Program of Sichuan Province (2017TD0004)

“13th Five-Year” National Key Research and Development Program of China (2016YFC1102200)
License Information

Text and Data Mining valid from 2018-02-24
More Information

Article History

First Online: 24 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.